-
Money and Myths Surrounding the COVID-19 Vaccines
PharmaSources/Nik Patel
December 02, 2021
Covid vaccines have demonstrated themselves to be highly effective, reducing the need for hospitalisation and risk of death by a massive 95%.
-
Recent Progress of Pharmaceutical Industry
Lin Zhang
November 22, 2021
2021 has been a wild year for the world, and the pharmaceutical industry as well. There have been significant developments in the past few months that have changed the state of the industry...
-
How Much Money Do Pharmaceutical Companies Really Make From COVID-19 Vaccines?
Lin Zhang
October 28, 2021
The COVID-19 pandemic led to widespread effects across the world, leading not only to economic challenges but also to advancements in medicine and pharmaceutical development.
-
Updates for the Janssen and AstraZeneca Vaccines Cross-contamination
Lin Zhang
July 13, 2021
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes COVID-19 pandemic has spread to over 220 countries and territories around the world as of July 2021.
-
Focusing on New Developments of COVID-19 Vaccines, Pharma Sources Insight August 2020 is Launched!
Pharma Sources Insight
August 27, 2020
Pharma Sources Insight (August 2020) focuses on new developments of COVID-19 vaccines and more!
-
WHO body says COVID-19 vaccines ‘may need to be updated’ for Omicron
ExpressPharma
January 13, 2022
The technical group, made up of independent experts, said it would consider a change in vaccination composition and stressed that shots needed to be more effective in protecting against infection.
-
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis
prnasia
December 03, 2021
The Centre for Gut Microbiota Research of the Faculty of Medicine at The Chinese University of Hong Kong, S.A.R., China (CU Medicine) is among the first in the world to discover that germs in our gut (gut microbiota)...
-
When could Moderna, J&J COVID-19 vaccines win full FDA approval?
firstwordpharma
August 25, 2021
A spokesperson for Johnson & Johnson says the company plans to file a biologics license application for its single-dose COVID-19 vaccine with the FDA "later in 2021," reported Fox News.
-
ICMR says Covaxin-Covishield combination shows better results
expresspharma
August 10, 2021
The Indian Council of Medical Research (ICMR), in its recent study, mentioned that mixing and matching of COVID-19 vaccines, namely Covaxin and Covishield, showed better results.
-
Mix of Covishield, Covaxin yields better results, finds ICMR Study
firstwordpharma
August 09, 2021
A study by ICMR involving 98 people, 18 of whom had inadvertently received Covishield as first dose and Covaxin as the second, showed that combining these two COVID-19 vaccines produced better immunogenicity than two doses of the same vaccine.